EUSA Pharma and Papa Giovanni XXIII Hospital, Italy, Provide Interim Analysis Data for Siltuximab-Treated COVID-19 Patients from the SISCO Study
HEMEL HEMPSTEAD, United Kingdom & BERGAMO, Italy--(BUSINESS WIRE)--Apr 1, 2020-- |!| Oelwein
HEMEL HEMPSTEAD, United Kingdom & BERGAMO, Italy--(BUSINESS WIRE)--Apr 1, 2020-- |!| Oelwein